查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594479

神经刺激设备市场：按产品、应用和最终用户 - 2025-2030 年全球预测

Neurostimulation Device Market by Product (Deep Brain Stimulation Devices, Gastric Electric Stimulation Devices, Sacral Nerve Stimulation Devices), Application (Alzheimer's, Chronic Pain Management, Epilepsy), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年神经刺激设备市场规模为96.5亿美元，预计2024年将达到107.2亿美元，复合年增长率为11.18%，到2030年将达到202.8亿美元。

神经刺激设备是一种医疗技术，用于向神经系统的特定区域提供电刺激，用于疼痛管理、復健和治疗各种神经系统疾病等目的。对神经刺激设备的需求源于其为慢性疼痛、癫痫、帕金森氏症和忧郁症等疾病提供非药物干预的能力，大大推动了医疗保健领域的需求。这些设备用于医院、诊所和家庭护理机构，并应用于深部脑部刺激、脊髓刺激和经颅磁刺激等多种领域。影响市场成长的主要因素包括人口老化、神经系统疾病盛行率的增加、技术进步以及对替代疗法的认识不断提高。最近的技术创新，例如微创手术和延长的电池寿命，为市场扩张提供了潜在的机会。抓住这些机会的建议包括投资于研发以提高设备有效性和患者定制，以及与医疗保健提供者合作以扩大采用范围。然而，市场成长面临着高昂的设备成本、严格的监管要求以及与使用相关的潜在副作用和併发症的挑战。此外，各个地区的报销政策可能会限制对这些设备的存取。儘管存在这些挑战，这个市场仍然存在创新机会，特别是无线神经刺激设备的开发以及个人化治疗计划的人工智慧集成，这可能会进一步推动采用和接受。此外，潜在的创新在于增强使用者介面技术，以改善患者和提供者与设备的互动。市场格局是动态的，研发方面的大量投资正在促进竞争格局。能够驾驭竞争格局、降低成本并开发有效的患者友善解决方案的公司将获得竞争优势，解决未满足的需求，并实现显着的业务成长。

主要市场统计
基准年[2023] 96.5亿美元
预测年份 [2024] 107.2亿美元
预测年份 [2030] 202.8亿美元
复合年增长率（%） 11.18%

市场动态：快速发展的神经刺激设备市场的关键市场洞察

供需的动态交互作用正在改变神经刺激设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 神经系统疾病盛行率增加
    • 忧郁症和慢性疼痛增加
    • 有利的报销方案和政府意识计划
  • 市场限制因素
    • 神经刺激设备高成本
    • 替代治疗方法的存在
  • 市场机会
    • 投资神经学研究和技术先进产品的开发
    • 闭合迴路神经调节的发展
  • 市场挑战
    • 缺乏训练有素的专业人员

波特的五力：驾驭神经刺激设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解神经刺激设备市场的外部影响

外部宏观环境因素在塑造神经刺激设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解神经刺激设备市场的竞争状况

对神经刺激设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵神经刺激设备市场供应商的绩效评估

FPNV定位矩阵是评估神经刺激设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划神经刺激设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对神经刺激设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 神经系统疾病增加
      • 忧郁症和慢性疼痛增加
      • 有利的报销方案和政府意识计划
    • 抑制因素
      • 神经刺激设备高成本
      • 替代治疗方法的存在
    • 机会
      • 投资神经学研究和技术先进产品的开发
      • 封闭回路型神经调节的发展
    • 任务
      • 缺乏训练有素的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章神经刺激设备市场：副产品

  • 深层脑部刺激器
  • 胃电刺激设备
  • 荐骨神经刺激器
  • 脊髓刺激设备
  • 迷走神经刺激设备

第七章神经刺激设备市场：依应用分类

  • 阿兹海默症
  • 慢性疼痛管理
  • 癫痫
  • 缺血
  • 帕金森氏症

第八章神经刺激设备市场：依最终用户分类

  • 医院
  • 科学研究室

第九章美洲神经刺激设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太神经刺激设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的神经刺激设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Neuropace, Inc.
  • Neurosigma, Inc.
  • St. Jude Medical Inc.
  • Synapse Biomedical, Inc.
Product Code: MRR-036C5CF3B4E1

The Neurostimulation Device Market was valued at USD 9.65 billion in 2023, expected to reach USD 10.72 billion in 2024, and is projected to grow at a CAGR of 11.18%, to USD 20.28 billion by 2030.

Neurostimulation devices are medical technologies used to deliver electrical stimulation to specific parts of the nervous system for therapeutic purposes, such as pain management, rehabilitation, and various neurological disorders. The necessity for neurostimulation devices arises from their ability to provide non-pharmacological interventions for conditions like chronic pain, epilepsy, Parkinson's disease, and depression, driving significant demand within the healthcare sector. These devices are utilized in hospitals, clinics, and home-care settings, with applications expanding across diverse areas such as deep brain stimulation, spinal cord stimulation, and transcranial magnetic stimulation. Key factors influencing market growth include the aging population, increasing prevalence of neurological disorders, advancements in technology, and growing awareness about alternative therapies. Recent innovations, like minimally invasive procedures and enhanced battery life, provide potential opportunities for market expansion. Recommendations to seize these opportunities include investing in R&D to enhance device efficacy and patient customization, as well as collaborating with healthcare providers to increase adoption. However, market growth is challenged by factors like high device costs, stringent regulatory requirements, and potential side effects or complications associated with use. Additionally, reimbursement policies in various regions can limit accessibility to these devices. Despite these challenges, the market presents opportunities for innovation, particularly in developing wireless neurostimulation devices and integrating AI for personalized treatment plans, which can further drive adoption and acceptance. Furthermore, the potential innovation lies in enhancing user-interface technologies to improve patient and provider interactions with the device. The nature of the neurostimulation device market is dynamic, with significant investments in R&D fostering a competitive landscape. Firms that can navigate regulatory landscapes, reduce costs, and develop patient-friendly, effective solutions stand to gain a competitive edge, cater to unmet needs, and achieve significant business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 9.65 billion
Estimated Year [2024] USD 10.72 billion
Forecast Year [2030] USD 20.28 billion
CAGR (%) 11.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurostimulation Device Market

The Neurostimulation Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of neurological disorders
    • Rising cases of depression and chronic pain
    • Favorable reimbursement scenario and government awareness programs
  • Market Restraints
    • High cost of neurostimulation devices
    • Presence of alternative therapeutic procedures
  • Market Opportunities
    • Investment for neurological R&D for technologically advanced products
    • Development of closed-loop neuromodulation
  • Market Challenges
    • Dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Neurostimulation Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurostimulation Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurostimulation Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurostimulation Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurostimulation Device Market

A detailed market share analysis in the Neurostimulation Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurostimulation Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurostimulation Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurostimulation Device Market

A strategic analysis of the Neurostimulation Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurostimulation Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Inc., Neuropace, Inc., Neurosigma, Inc., St. Jude Medical Inc., and Synapse Biomedical, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurostimulation Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Deep Brain Stimulation Devices, Gastric Electric Stimulation Devices, Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices, and Vagus Nerve Stimulation Devices.
  • Based on Application, market is studied across Alzheimer's, Chronic Pain Management, Epilepsy, Ischemia, and Parkinson's Disease.
  • Based on End User, market is studied across Hospitals and Scientific Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of neurological disorders
      • 5.1.1.2. Rising cases of depression and chronic pain
      • 5.1.1.3. Favorable reimbursement scenario and government awareness programs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of neurostimulation devices
      • 5.1.2.2. Presence of alternative therapeutic procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Investment for neurological R&D for technologically advanced products
      • 5.1.3.2. Development of closed-loop neuromodulation
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurostimulation Device Market, by Product

  • 6.1. Introduction
  • 6.2. Deep Brain Stimulation Devices
  • 6.3. Gastric Electric Stimulation Devices
  • 6.4. Sacral Nerve Stimulation Devices
  • 6.5. Spinal Cord Stimulation Devices
  • 6.6. Vagus Nerve Stimulation Devices

7. Neurostimulation Device Market, by Application

  • 7.1. Introduction
  • 7.2. Alzheimer's
  • 7.3. Chronic Pain Management
  • 7.4. Epilepsy
  • 7.5. Ischemia
  • 7.6. Parkinson's Disease

8. Neurostimulation Device Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Scientific Research Laboratories

9. Americas Neurostimulation Device Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurostimulation Device Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurostimulation Device Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. Boston Scientific Corporation
  • 4. Medtronic, Inc.
  • 5. Neuropace, Inc.
  • 6. Neurosigma, Inc.
  • 7. St. Jude Medical Inc.
  • 8. Synapse Biomedical, Inc.

LIST OF FIGURES

  • FIGURE 1. NEUROSTIMULATION DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROSTIMULATION DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROSTIMULATION DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROSTIMULATION DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ALZHEIMER'S, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2023